Bob Casper has given many couples new hope for a healthy pregnancy. As
a leader in fertility treatment, Dr. Casper has won international
recognition for his research and patient care.
Casper's research led to the development of a new treatment, originally
approved for the treatment of breast cancer, for ovulation
stimulation in infertile women that doubles a patient's chances of
pregnancy compared to older treatment. He is also leading research in
endometriosis - one of the most common causes of pelvic pain and
infertility in women - and is developing a genetic test that would
detect young girls at risk of the disease, allowing for preventative
by innovation and new ideas, Dr. Casper has also initiated studies in
melatonin production in night shift workers. Melatonin has been shown
to be an anti-cancer hormone and decreased levels have been connected
to increased incidence of prostate, colon and breast cancers in shift
workers. After studying the impact of light wavelengths on melatonin
during peak production hours, Dr. Casper has proposed a new device that
would protect individuals from depleted melatonin levels and reduce
risk of cancer, as well as preventing depression and
Casper is also doing exciting work in cord blood banking and in
research to extend the medical applications of banked cord blood
samples. He founded Canada's first cord blood bank at Mount Sinai
Hospital, and as Scientific Director of Insception Biosciences (the
company now leading the program) he continues to play a key role in
cord blood banking and stem cell research.
Dr Casper is studying the possibility of reducing the risk of breast
cancer in menopausal women on hormone replacement therapy by the
addition of an aromatase inhibitor.
Casper is Medical Director for the Toronto Centre for Advanced
Reproductive Technology, an independent fertility clinic and leading
fertility research centre.